The Valley Desk

NCT01434498 · Interventional trial

GS-5885, GS-9451, Tegobuvir and Ribavirin (RBV) in Interferon Ineligible or Intolerant Subjects With Chronic Genotype 1a or 1b Hepatitis C Virus (HCV) Infection

Overall registry status Completed

Phase 2

Conditions Chronic Genotype 1a or 1b HCV Infection

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov